US Broker Ratings

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring the 32% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $4.58..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 16.36% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (BIO), a prominent player in the healthcare sector, is attracting investor attention with its strong potential upside of 16.36%. As a company operating..

Encompass Health Corporation (EHC) Stock Analysis: A 32% Upside in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC) is a dominant player in the healthcare sector, specifically within the medical care facilities industry. Known for its comprehensive post-acute healthcare..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a Potential 11.71% Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to solidify its position as a key player in the medical instruments and..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Healthcare Giant with a 5.45% Upside Potential

For investors eyeing opportunities in the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents an intriguing option. With a storied history dating back to 1781,..

Amgen Inc. (AMGN) Stock Report: Evaluating the 106% Return on Equity and Market Prospects

For individual investors keeping a keen eye on the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling case with its impressive return on equity (ROE)..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth with a 2.28% Upside Potential

Molina Healthcare Inc (NYSE: MOH) is a prominent player in the healthcare sector, specifically within the healthcare plans industry. As of its latest trading session, the..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 33.92% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out in the healthcare sector as a dynamic force within the specialty and generic drug manufacturing industry. Headquartered in San..

ICON plc (ICLR) Stock Analysis: Unpacking the 37% Upside Potential

Investors eyeing the healthcare sector may want to take a closer look at ICON plc (NASDAQ: ICLR), a leading player in the diagnostics and research industry...

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating Growth and Valuation in the Healthcare Sector

For investors eyeing opportunities within the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) presents an intriguing case. As a major player in the medical care facilities..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Growth Potential and Investor Outlook with a Strong Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP), a key player in the healthcare sector specializing in diagnostics and research, has emerged as a robust performer with a market..

Abbott Laboratories (ABT) Stock Analysis: A 14.64% Potential Upside Amidst Strong Buy Ratings

Abbott Laboratories (NYSE: ABT) stands out as a formidable player in the healthcare sector, specifically within the medical devices industry. With a substantial market capitalization of..

Incyte Corporation (INCY) Stock Analysis: Growth Potential with a 5.75% Upside and Strong Revenue Growth

Investors looking for opportunities in the biotechnology sector might find Incyte Corporation (NASDAQ: INCY) particularly compelling. With a market capitalization of $20.15 billion, Incyte has positioned..

Viatris Inc. (VTRS) Stock Report: Navigating the Healthcare Giant’s 3.22% Dividend Yield and Revenue Growth

Viatris Inc. (NASDAQ: VTRS), a notable player in the healthcare sector, continues to capture investor attention with its substantial market presence and intriguing financial indicators. As..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Navigating the Highs of a 27% Potential Upside

Revolution Medicines, Inc. (RVMD), a prominent player in the biotechnology sector, is capturing the attention of investors with its ambitious foray into precision oncology. Headquartered in..

Genmab A/S (GMAB) Stock Analysis: A 27% Upside Potential in the Biotech Arena

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, has caught the attention of investors with its robust pipeline and strategic collaborations. Headquartered in..

Haleon plc (HLN) Stock Analysis: A Solid Healthcare Player with 7.75% Upside Potential

Haleon plc (HLN), a formidable entity in the healthcare sector, continues to capture investor attention with its robust market presence and a promising 7.75% potential upside...

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a Potential 8.76% Upside in Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has piqued investor interest with a potential upside of 8.76%, according to recent..

Eli Lilly (LLY) Stock Analysis: Exploring Its 15% Upside Potential and Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor interest with its impressive growth metrics and promising future outlook...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds